SLC5A2 and diabetes mellitus: However, it must be recognized that diabetes is a significant factor for HF hospitalization, and the cardiac mortality factor were not different between groups in the two SGLT2 inhibitor studies [OR = 0.88 (95%CI 0.73 − 1.07) and OR = 0.88 (95%CI 0.74 − 1.05), respectively].